inventionINDEX | is a specialized resource designed to track, analyze, and highlight innovation trends, patent activity, and R&D (Research and Development) efforts across sectors and geographic regions. As part of our broader suite of services focused on R&D tax incentives, the inventionINDEX serves as a centralized platform to:

  1. Showcase Innovation:
    • Presents state-specific innovation highlights, spotlighting breakthrough inventions and patented technologies developed.
    • Provides insights into emerging trends, sectors, and innovators driving regional economic growth.
  2. Promote Awareness:
    • Acts as a public-facing tool to celebrate inventors and companies contributing to technological progress.
    • Encourages organizations to leverage R&D tax credits by illustrating real-world examples of innovation-based success stories.
  3. State-Specific Insights:
    • Organizes data by state, allowing users to explore localized innovation ecosystems, industry clusters, and regulatory environments relevant to R&D.

inventionINDEX

What are Patent Grants?

In a September 2025 report by the Swanson Reed Patent Grants Thinktank, the authors propose reforming the US patent system, citing examination backlogs, low-quality grants, and litigation by Non-Practicing Entities that increase costs and hinder innovation. They recommend a Collaborative Examination Pathway (CEP), an optional, front-loaded USPTO track fostering early collaboration between applicant and examiner using AI tools and a secure digital platform to improve patent quality, shorten wait times, and strengthen legal certainty. The report also calls for a federal grant of up to $50,000 per international patent family to help small businesses cover patenting costs and suggests using Swanson Reed’s inventionINDEX — which links patent output to GDP growth — as a simple metric to assess innovation and measure program outcomes. Learn more

Read the Document

Use the interactive map below to access over 5 years of data and analysis for all regions, representing over 1500 individual analyses: